Published in J Gastroenterol Hepatol on March 19, 1992
The ATP 30-a scale for measuring medical students' attitudes to psychiatry. Med Educ (1982) 1.81
Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis (2007) 1.73
Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2). Transplantation (2002) 1.64
Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol (1995) 1.48
Balancing utility and need by means of donor-to-recipient matching: a challenging problem. Am J Transplant (2013) 1.43
European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology (1999) 1.38
Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation. J Hepatol (2001) 1.19
New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol (2006) 1.17
Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology (1992) 1.12
Nonadherent behaviors after solid organ transplantation. Transplant Proc (2011) 1.12
Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease. Hepatology (1994) 1.05
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria. Am J Transplant (2007) 1.03
Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. J Viral Hepat (2007) 1.02
Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries. Dig Liver Dis (2009) 1.01
Bone metabolism in orthotopic liver transplantation: a prospective study. Liver Transpl Surg (1998) 0.99
Veno occlusive disease: update on clinical management. World J Gastroenterol (2007) 0.98
Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals. Transplant Proc (2006) 0.98
The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation. J Hepatol (2000) 0.93
Histology predicts cirrhotic evolution of post transplant hepatitis C. Gut (2002) 0.89
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. Am J Transplant (2011) 0.88
De novo tumors are a major cause of late mortality after orthotopic liver transplantation. Transplant Proc (2009) 0.88
Risk of Kaposi sarcoma after solid-organ transplantation: multicenter study in 4,767 recipients in Italy, 1970-2006. Transplant Proc (2009) 0.87
Microwave thermal ablation for hepatocarcinoma: six liver transplantation cases. Transplant Proc (2011) 0.87
Serum malondialdehyde and mitochondrial aspartate aminotransferase activity as markers of chronic alcohol intake and alcoholic liver disease. Ital J Gastroenterol (1993) 0.86
Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. Transplant Proc (2009) 0.86
HBV and HCV infections in heart transplant recipients. J Heart Lung Transplant (2001) 0.86
The protective effects of L-arginine after liver ischaemia/reperfusion injury in a pig model. J Pathol (1997) 0.86
Alcohol abuse and de novo tumors in liver transplantation. Transplant Proc (2009) 0.85
Progression of hepatocellular carcinoma before liver transplantation: dropout or liver transplantation? Transplant Proc (2009) 0.84
The impact of hepatitis C and biliary complications on patient and graft survival following liver transplantation. Am J Transplant (2009) 0.84
Zinc, iron, and peroxidation in liver tissue. Cumulative effects of alcohol consumption and virus-mediated damage--a preliminary report. Biol Trace Elem Res (1995) 0.83
Fibrosis progression and the pros and cons of antiviral therapy for hepatitis C virus recurrence after liver transplantation: a review. Transplant Proc (2010) 0.82
11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease. J Clin Endocrinol Metab (1993) 0.81
Untoward effects following combined neuroleptic-lithium therapy. Cardiac arrhythmias and seizure. Can J Psychiatry (1980) 0.81
Neuropsychological and neurophysiological evaluation in cirrhotic patients with minimal hepatic encephalopathy undergoing liver transplantation. Transplant Proc (2005) 0.81
Prognostic evaluation of the donor risk index among a prospective cohort of Italian patients undergoing liver transplantation. Transplant Proc (2009) 0.81
Teaching interviewing skills by encountering patients. J Med Educ (1979) 0.81
Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr virus (EBV) infection. Transpl Int (2000) 0.81
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. Transplant Proc (2010) 0.80
Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs. Ital J Gastroenterol (1992) 0.80
Microvascular autonomic dysfunction may justify false-positive stress myocardial perfusion imaging in patients with liver cirrhosis undergoing liver transplantation. Transplant Proc (2008) 0.79
Regional cerebral blood flow changes in patients with cirrhosis assessed with 99mTc-HM-PAO single-photon emission computed tomography: effect of liver transplantation. J Hepatol (1998) 0.79
Management of hepatitis C virus infection recurrence after liver transplantation: an overview. Transplant Proc (2011) 0.79
The transjugular route: the key hole to the liver world. Dig Liver Dis (2006) 0.79
The effect of recurrence of HCV infection of life after liver transplantation. Transpl Int (1998) 0.78
Early predictive markers of irreversible graft dysfunction after liver transplantation. Transplant Proc (1994) 0.78
Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: presentation and response to treatment. Acta Haematol (2008) 0.78
Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation. Transplant Proc (2011) 0.78
A typical psychosis with reversible primitive reflexes. Can J Psychiatry (1980) 0.77
Risk factors in liver retransplantation: a single-center experience. Transplant Proc (2011) 0.77
Post-transplant lymphoproliferative disorders in liver transplanted patients: a single-centre experience. Anticancer Res (2010) 0.77
[A clinico-endoscopic study on cicatrization of lesions and prevention of recurrences in patients with liver cirrhosis and peptic ulcer]. G Clin Med (1990) 0.77
Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation? Transplant Proc (2012) 0.77
Bone metabolism and gonad function in male patients undergoing liver transplantation: a two-year longitudinal study. Osteoporos Int (2001) 0.77
Combined liver and kidney transplantation: analysis of Padova experience. Transplant Proc (2007) 0.77
Long-term evaluation of cognitive function and cerebral metabolism in liver transplanted patients. Transplant Proc (2009) 0.76
Measuring interviewing skill: the Queen's University Interviewer Rating Scale (QUIRS). Can Psychiatr Assoc J (1972) 0.76
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. Transplant Proc (2013) 0.76
Role-playing: a method of teaching interpersonal skills. Can Psychiatr Assoc J (1972) 0.76
HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma. Transplant Proc (2008) 0.76
Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation. Transfusion (1994) 0.76
Laboratory test scores to aid identification of primary nonfunction of liver transplants. Clin Chem (1995) 0.76
Managing severe alcoholic hepatitis complicated by renal failure. Q J Med (1993) 0.75
Hepatitis C infection in patients with chronic kidney disease. Int J Artif Organs (2008) 0.75
Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension (Br J Surg 2010; 97: 910-916). Br J Surg (2010) 0.75
Natural alpha-IFN in HCV recurrence after liver transplantation. Transplant Proc (2001) 0.75
Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: impact on survival or HCV recurrence timing. Transplant Proc (2003) 0.75
Liver transplantation and pregnancy. Int J Gynaecol Obstet (1995) 0.75
[Neuroendocrine tumors and liver transplantation: review based on a case report]. Orv Hetil (1997) 0.75
A case of atypical depression. Can J Psychiatry (1988) 0.75
The metaphysical nature of psychotherapy. Am J Psychiatry (1980) 0.75
Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation. Minerva Med (2010) 0.75
Gastrectomy, lack of gastric first pass metabolism of ethanol and alcoholic liver disease. Results of a multicentre study. Ital J Gastroenterol Hepatol (1997) 0.75
[Ulcer and hepatic cirrhosis. Epidemiologic and clinical correlations]. Minerva Med (1991) 0.75
Algorithm for prioritization of patients on the waiting list for liver transplantation. Transplant Proc (2007) 0.75
Physiological and clinical implications of proANP(1-98) circulating levels in the perioperative phase of liver transplantation. Clin Chim Acta (2001) 0.75
Fulminant hepatic failure: the issue of patient selection for hazardous liver assistance. Transplant Proc (2000) 0.75
Symposium on the teaching of psychiatry. Canada: Queen's University, Kingston, Ontario. Br J Psychiatry (1983) 0.75
GH/GHBP changes in the perioperative course of liver transplantation: pathophysiologic and clinical implications. Transplant Proc (2001) 0.75
Comparison between nifedipine and carvedilol in the treatment of de novo arterial hypertension after liver transplantation: preliminary results of a controlled clinical trial. Transplant Proc (2005) 0.75
[Preservation of the liver with the University of Wisconsin solution. Clinical and experimental aspects]. Minerva Gastroenterol Dietol (1992) 0.75
Mental competence and consent to treatment. Can J Psychiatry (1980) 0.75
Two cases of Kaposi's sarcoma in renal and liver transplant recipients treated with interferon. Clin Transplant (1996) 0.75
Alcohol metabolism in the upper digestive tract: its implications with respect to carcinogenesis. Eur J Cancer Prev (1992) 0.75
Protective effect of L-arginine on liver ischemia-reperfusion injury. Transplant Proc (1997) 0.75
Functional and morphological graft monitoring after liver transplantation. Clin Chim Acta (2001) 0.75
Human natriuretic factor in cirrhotic patients undergoing orthotopic liver transplantation. Transpl Int (1995) 0.75
Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis. Transplant Proc (2009) 0.75
International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT CANDIDATES. Transplantation (2017) 0.75
Energy expenditure (EE) and substrate utilization (SU) in the perioperative period in orthotopic liver transplantation (OLTX). Rocz Akad Med Bialymst (1995) 0.75
Histological features of donor grafts for orthotopic liver transplantation. Transplant Proc (2001) 0.75
The Helping Professions Group: interpersonal dimensions in health sciences education. J Med Educ (1979) 0.75